NIWA; Rinpei
Patent Applications and Registrations
Patent applications and USPTO patent grants for NIWA; Rinpei.The latest application filed is for "bispecific antibody which binds to cd40 and epcam".
Company Profile
1.26.36
- NIWA; Rinpei - Tokyo JP
- Niwa; Rinpei - Machida JP
- NIWA; Rinpei - Machida-shi JP
Patent Activity
| Patent | Date |
|---|---|
| BISPECIFIC ANTIBODY WHICH BINDS TO CD40 AND EpCAM App 20210380713 - NAKAYAMA; Makoto ; et al. | 2021-12-09 |
| Antibody Composition App 20210380684 - NIWA; Rinpei ; et al. | 2021-12-09 |
| Heterodimer protein composition Grant 10,494,437 - Niwa , et al. De | 2019-12-03 |
| Antibody variants composition Grant 10,040,861 - Niwa , et al. August 7, 2 | 2018-08-07 |
| Heterodimer Protein Composition App 20170362323 - NIWA; Rinpei ; et al. | 2017-12-21 |
| Heterodimer protein composition Grant 9,714,291 - Niwa , et al. July 25, 2 | 2017-07-25 |
| Anti-death Receptor 3 (dr3) Antagonistic Antibodies With Reduced Agonistic Activity App 20170190781 - MILLS; David ; et al. | 2017-07-06 |
| Antibody Variants Composition App 20170166650 - NIWA; Rinpei ; et al. | 2017-06-15 |
| Medicament comprising recombinant antibody against chemokine receptor CCR4 Grant 9,675,625 - Shitara , et al. June 13, 2 | 2017-06-13 |
| Antibody variants composition Grant 9,556,279 - Niwa , et al. January 31, 2 | 2017-01-31 |
| Recombinant antibody composition Grant 9,475,886 - Shitara , et al. October 25, 2 | 2016-10-25 |
| Recombinant Antibody Composition App 20160108136 - SHITARA; Kenya ; et al. | 2016-04-21 |
| Recombinant antibody composition Grant 8,883,981 - Shitara , et al. November 11, 2 | 2014-11-11 |
| Anti-CD4 antibody Grant 8,877,913 - Nakagawa , et al. November 4, 2 | 2014-11-04 |
| Heterodimer Protein Composition App 20140120581 - NIWA; Rinpei ; et al. | 2014-05-01 |
| Method for producing recombinant antibody and antibody fragment thereof Grant 8,632,996 - Shitara , et al. January 21, 2 | 2014-01-21 |
| Medicament Comprising Recombinant Antibody Against Chemokine Receptor Ccr4 App 20130295045 - SHITARA; Kenya ; et al. | 2013-11-07 |
| Effector function enhanced recombinant antibody composition Grant 8,492,526 - Shitara , et al. July 23, 2 | 2013-07-23 |
| Medicament comprising recombinant antibody against chemokine receptor CCR4 Grant 8,491,902 - Shitara , et al. July 23, 2 | 2013-07-23 |
| Anti-cd4 Antibody App 20130177944 - NAKAGAWA; Tomoaki ; et al. | 2013-07-11 |
| Anti-CD4 antibody Grant 8,399,621 - Nakagawa , et al. March 19, 2 | 2013-03-19 |
| Gene Recombinant Antibody And Antibody Fragment Thereof App 20120276090 - SHITARA; Kenya ; et al. | 2012-11-01 |
| Method for treating the Th2-mediated disease Grant 8,197,814 - Shitara , et al. June 12, 2 | 2012-06-12 |
| Effector Function Enhanced Recombinant Antibody Composition App 20120022238 - SHITARA; Kenya ; et al. | 2012-01-26 |
| Method Of Depleting Regulatory T Cell App 20120020962 - UEDA; Ryuzo ; et al. | 2012-01-26 |
| Antibody Variants Composition App 20120010387 - NIWA; Rinpei ; et al. | 2012-01-12 |
| Genetically Recombinant Antibody Composition Capable Of Binding Specifically To Ganglioside Gm2 App 20110236374 - Shitara; Kenya ; et al. | 2011-09-29 |
| Effector function enhanced recombinant antibody composition Grant 7,994,290 - Shitara , et al. August 9, 2 | 2011-08-09 |
| Recombinant antibody composition Grant 7,923,538 - Shitara , et al. April 12, 2 | 2011-04-12 |
| Recombinant Antibody Composition App 20110009600 - SHITARA; Kenya ; et al. | 2011-01-13 |
| Anti-cd4 Antibody App 20100310573 - NAKAGAWA; Tomoaki ; et al. | 2010-12-09 |
| Method for Treating the TH2-Mediated Disease App 20100221178 - SHITARA; Kenya ; et al. | 2010-09-02 |
| Method of Depleting Regulatory T Cell App 20100150917 - UEDA; Ryuzo ; et al. | 2010-06-17 |
| Antibody composition-containing medicament Grant 7,691,568 - Niwa , et al. April 6, 2 | 2010-04-06 |
| Method for treating Th2-mediated disease Grant 7,666,418 - Shitara , et al. February 23, 2 | 2010-02-23 |
| Medicaments Comprising Gene Recombinant Antibody Against Ganglioside Gd3 App 20090226399 - Shitara; Kenya ; et al. | 2009-09-10 |
| Antibody Composition Specifically Binding to Ganglioside Gm App 20090028877 - Iida; Shigeru ; et al. | 2009-01-29 |
| Effector Function Enhanced Recombinant Antibody Composition App 20090004186 - SHITARA; Kenya ; et al. | 2009-01-01 |
| Antibody against human insulin-like growth factor Grant 7,438,911 - Shitara , et al. October 21, 2 | 2008-10-21 |
| Method for Treating CCR4-Related Diseases App 20080213266 - Iida; Shigeru ; et al. | 2008-09-04 |
| Medicaments Comprising Gene Recombinant Antibody Against Ganglioside Gd3 App 20080166345 - SHITARA; Kenya ; et al. | 2008-07-10 |
| IL-5R-specific antibody composition App 20080095765 - Ilda; Shigeru ; et al. | 2008-04-24 |
| Recombinant antibody composition App 20070148165 - Shitara; Kenya ; et al. | 2007-06-28 |
| Medicine containing genetically modified antibody against chemokine receptor ccr4 App 20070020263 - Shitara; Kenya ; et al. | 2007-01-25 |
| Antibody against human insulin-like growth factor App 20060165695 - Shitara; Kenya ; et al. | 2006-07-27 |
| Method of depleting regulatory T cell App 20060034841 - Ueda; Ryuzo ; et al. | 2006-02-16 |
| Recombinant antibody and antibody fragment Grant 6,989,145 - Shitara , et al. January 24, 2 | 2006-01-24 |
| CCR4-specific antibody composition App 20050287138 - Iida, Shigeru ; et al. | 2005-12-29 |
| Drugs containing genetically modified antibody against ganglioside gd3 App 20050260206 - Shitara, Kenya ; et al. | 2005-11-24 |
| IL-5R-specific antibody composition App 20050226867 - Iida, Shigeru ; et al. | 2005-10-13 |
| Method for treating Th2-mediated disease App 20050187380 - Shitara, Kenya ; et al. | 2005-08-25 |
| Therapeutic agent for patients having human FcgammaRIIIa App 20050031613 - Nakamura, Kazuyasu ; et al. | 2005-02-10 |
| Antibody composition-containing medicament App 20040109865 - Niwa, Rinpei ; et al. | 2004-06-10 |
| Gene recombinant antibody and antibody fragment thereof App 20020098527 - Shitara, Kenya ; et al. | 2002-07-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 